{"id":3983,"date":"2020-09-15T13:52:33","date_gmt":"2020-09-15T12:52:33","guid":{"rendered":"https:\/\/www.ab-science.com\/accueil\/"},"modified":"2025-05-21T11:28:26","modified_gmt":"2025-05-21T10:28:26","slug":"accueil","status":"publish","type":"page","link":"https:\/\/www.ab-science.com\/fr\/","title":{"rendered":"Accueil"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row css=\u00a0\u00bb.vc_custom_1601559325217{margin-top: 0px !important;padding-top: 0px !important;}\u00a0\u00bb][vc_column]\n\t\t\t\t<p class=\"rs-p-wp-fix\"><\/p>\n\t\t\t\t<sr7-module data-alias=\"slider-1\" data-id=\"2\" id=\"SR7_2_1\" data-version=\"6.7.57\">\n\t\t\t\t\t<sr7-adjuster><\/sr7-adjuster>\n\t\t\t\t\t<sr7-content>\n\t\t\t\t\t\t<sr7-slide id=\"SR7_2_1-1\" data-key=\"1\">\n\t\t\t\t\t\t\t<sr7-bg id=\"SR7_2_1-1-slidebg\" class=\"sr7-layer\"><noscript><img decoding=\"async\" src=\"https:\/\/www.ab-science.com\/wp-content\/uploads\/2023\/02\/water-molecules-science-or-medical-background-wit-2022-12-16-21-47-06-utc-scaled.jpg\" alt=\"\" title=\"Water molecules. Science or medical background with molecules and atoms. 3d render\"><\/noscript><\/sr7-bg>\n\t\t\t\t\t\t\t<sr7-txt id=\"SR7_2_1-1-0\" class=\"sr7-layer\">D\u00e9velopper des th\u00e9rapies innovantes dans des maladies \u00e0 fort besoin m\u00e9dical<\/sr7-txt>\n\t\t\t\t\t\t<\/sr7-slide>\n\t\t\t\t\t\t<sr7-slide id=\"SR7_2_1-3\" data-key=\"3\">\n\t\t\t\t\t\t<\/sr7-slide>\n\t\t\t\t\t<\/sr7-content>\n\t\t\t\t<\/sr7-module>\n\t\t\t\t<script>\n\t\t\t\t\twindow.SR7 ??={};SR7.PMH ??={}; SR7.PMH[\"SR7_2_1\"] = {cn:100,state:false,fn: function() { if (window._tpt!==undefined && window._tpt.prepareModuleHeight !== undefined) {  _tpt.prepareModuleHeight({id:\"SR7_2_1\",el:[620],type:'standard',shdw:'0',gh:[620],gw:[1240],vpt:['-200px'],size:{fullWidth:true, fullHeight:false},mh:'0',onh:0,onw:0,bg:{color:'transparent'},plType:'0',plColor:'#ffffff'});   SR7.PMH[\"SR7_2_1\"].state=true;} else if(SR7.PMH[\"SR7_2_1\"].cn-->0)\tsetTimeout( SR7.PMH[\"SR7_2_1\"].fn,19);}};SR7.PMH[\"SR7_2_1\" ].fn();\n\t\t\t\t<\/script>\n[\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-6a4787e363ea6\" data-id=\"6a4787e363ea6\" data-height=\"40\" data-height-mobile=\"20\" data-height-tab=\"40\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"20\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"dt-fancy-separator h2-size accent-title-color accent-border-color\" style=\"width: 100%;\"><div class=\"dt-fancy-title\"><span class=\"separator-holder separator-left\"><\/span>Derni\u00e8res actualit\u00e9s<span class=\"separator-holder separator-right\"><\/span><\/div><\/div><div class=\"ult-spacer spacer-6a4787e363f34\" data-id=\"6a4787e363f34\" data-height=\"20\" data-height-mobile=\"10\" data-height-tab=\"20\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"10\" style=\"clear:both;display:block;\"><\/div><style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on.classic-layout-list article {\n  padding-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on.classic-layout-list article:first-of-type {\n  margin-top: 0;\n  padding-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.classic-layout-list.mode-list .post-entry-content {\n  width: calc(100% - );\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.classic-layout-list.mode-list .no-img .post-entry-content {\n  width: 100%;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .filter-bg-decoration .filter-categories a.act {\n  color: #fff;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.mode-masonry) article:first-of-type,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.mode-masonry) article.visible.first:not(.product) {\n  margin-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on:not(.mode-masonry) article {\n  margin-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on:not(.mode-masonry) article:first-of-type,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on:not(.mode-masonry) article.visible.first:not(.product) {\n  margin-top: 0;\n  padding-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-thumbnail-wrap {\n  padding: 0px 0px 0px 0px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.enable-bg-rollover .post-thumbnail-rollover:after {\n  background: -webkit-linear-gradient();\n  background: linear-gradient();\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  width: 44px;\n  height: 44px;\n  line-height: 44px;\n  border-radius: 100px;\n  margin: -22px 0 0 -22px;\n  border-width: 0px;\n  color: #ffffff;\n}\n.bottom-overlap-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  margin-top: -72px;\n}\n.gradient-overlay-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico,\n.content-rollover-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  margin: 0 0 10px;\n}\n.content-align-center.gradient-overlay-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico,\n.content-align-center.content-rollover-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  margin: 0 auto 10px;\n}\n.dt-icon-bg-on.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  background: rgba(255,255,255,0.3);\n  box-shadow: none;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico > span,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico:before {\n  font-size: 32px;\n  line-height: 44px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico > span,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico:before {\n  color: #ffffff;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-title,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.owl-carousel .entry-title {\n  margin-bottom: 5px;\n  font-weight: bold;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-meta {\n  margin-bottom: 15px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .portfolio-categories {\n  margin-bottom: 15px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-excerpt {\n  margin-bottom: 5px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.centered-layout-list) .post-entry-content {\n  padding: 25px 30px 30px 30px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.centered-layout-list):not(.content-bg-on):not(.mode-list) .no-img .post-entry-content {\n  padding: 0;\n}\n@media screen and (max-width: ) {\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 article {\n    -ms-flex-flow: column nowrap;\n    flex-flow: column nowrap;\n    margin-top: 20px;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on article {\n    border: none;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.content-bg-on.centered-layout-list article {\n    padding: 0;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.blog-shortcode.dividers-on article,\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on.classic-layout-list article {\n    margin-top: 20px;\n    padding: 0;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.blog-shortcode.dividers-on article:first-of-type,\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on.classic-layout-list article:first-of-type {\n    padding: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-thumbnail-wrap,\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-entry-content {\n    width: 100%;\n    margin: 0;\n    top: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-thumbnail-wrap {\n    padding: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-entry-content:after {\n    display: none;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .project-even .post-thumbnail-wrap,\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.centered-layout-list .post-thumbnail-wrap {\n    -ms-flex-order: 0;\n    order: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.centered-layout-list .post-entry-title-content {\n    -ms-flex-order: 1;\n    order: 1;\n    width: 100%;\n    padding: 20px 20px 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.centered-layout-list .post-entry-content {\n    -ms-flex-order: 2;\n    order: 2;\n    padding-top: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .fancy-categories {\n    top: 10px;\n    left: 10px;\n    bottom: auto;\n    right: auto;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .fancy-date a {\n    top: 10px;\n    right: 10px;\n    left: auto;\n    bottom: auto;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-entry-content {\n    padding: 20px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-title {\n    margin: 3px 0 5px;\n    font-size: 20px;\n    line-height: 26px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-meta {\n    margin: 5px 0 5px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-excerpt {\n    margin: 15px 0 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-details {\n    margin: 5px 0 10px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-details.details-type-link {\n    margin-bottom: 2px;\n  }\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid {\n  grid-row-gap: 30px;\n  grid-column-gap: 30px;\n  grid-template-columns: repeat(auto-fill,minmax(,1fr));\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid .double-width {\n  grid-column: span 2;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid,\n.no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid {\n  display: flex;\n  flex-flow: row wrap;\n  margin: -15px;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid .wf-cell,\n.no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid .wf-cell {\n  flex: 1 0 ;\n  max-width: 100%;\n  padding: 15px;\n  box-sizing: border-box;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n  grid-template-columns: repeat(3,1fr);\n  grid-template-rows: auto;\n  grid-column-gap: 30px;\n  grid-row-gap: 30px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .double-width {\n  grid-column: span 2;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n  margin: -15px;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell {\n  width: 33.333333333333%;\n  padding: 15px;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n  width: calc(33.333333333333%) * 2;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width:not(.centered-layout-list):not(.content-bg-on) .dt-css-grid {\n  grid-row-gap: 0px;\n}\n@media screen and (max-width: 1199px) {\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n    grid-template-columns: repeat(3,1fr);\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell {\n    width: 33.333333333333%;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n    width: calc(33.333333333333%)*2;\n  }\n}\n@media screen and (max-width: 991px) {\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n    grid-template-columns: repeat(2,1fr);\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell {\n    width: 50%;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n    width: calc(50%)*2;\n  }\n}\n@media screen and (max-width: 767px) {\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n    grid-template-columns: repeat(1,1fr);\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .double-width {\n    grid-column: span 1;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell {\n    width: 100%;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n    width: calc(100%)*2;\n  }\n}<\/style><div class=\"blog-shortcode blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 mode-grid classic-layout-list content-bg-on jquery-filter scale-img dt-css-grid-wrap dt-icon-bg-off resize-by-browser-width loading-effect-move-up description-under-image \" data-padding=\"15px\" data-cur-page=\"1\" data-post-limit=\"-1\" data-pagination-mode=\"none\" data-desktop-columns-num=\"3\" data-v-tablet-columns-num=\"2\" data-h-tablet-columns-num=\"3\" data-phone-columns-num=\"1\" data-width=\"0px\" data-columns=\"0\"><div class=\"dt-css-grid\" ><div class=\"visible wf-cell\" data-post-id=\"10815\" data-date=\"2026-07-01T07:55:58+02:00\" data-name=\"AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros\"><article class=\"post project-odd visible no-img post-10815 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros\" data-date=\"2026-07-01T07:55:58+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-le-succes-dun-placement-prive-de-23-millions-deuros\/\" title=\"AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros\" rel=\"bookmark\">AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/07\/01\/\" title=\"7h55\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-07-01T07:55:58+02:00\">1 juillet 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 01\/07\/2026 \u2013 AB Science annonce aujourd&rsquo;hui le succ\u00e8s d&rsquo;une augmentation de capital d&rsquo;un montant brut total de 2,3 millions d\u2019euros souscrite par un nombre limit\u00e9 d&rsquo;investisseurs [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-le-succes-dun-placement-prive-de-23-millions-deuros\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10790\" data-date=\"2026-06-29T07:27:17+02:00\" data-name=\"AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute\"><article class=\"post project-odd visible no-img post-10790 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute\" data-date=\"2026-06-29T07:27:17+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-lachevement-de-letape-3-de-la-phase-1-evaluant-la-combinaison-dab8939-et-du-venetoclax-dans-le-traitement-de-la-lma-refractaire-ou-en-rechute\/\" title=\"AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute\" rel=\"bookmark\">AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/06\/29\/\" title=\"7h27\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-06-29T07:27:17+02:00\">29 juin 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 29\/06\/2026 \u2013\u00a0AB Science fait aujourd\u2019hui le point sur l\u2019\u00e9tude de phase 1 de la mol\u00e9cule AB8939 et l\u2019ach\u00e8vement de l\u2019\u00e9tape 3, \u00e9valuant la combinaison d\u2019AB8939 + v\u00e9n\u00e9toclax chez des patients atteints de leuc\u00e9mie my\u00e9lo\u00efde aigu\u00eb [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-lachevement-de-letape-3-de-la-phase-1-evaluant-la-combinaison-dab8939-et-du-venetoclax-dans-le-traitement-de-la-lma-refractaire-ou-en-rechute\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10773\" data-date=\"2026-06-17T17:47:20+02:00\" data-name=\"Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042\"><article class=\"post project-odd visible no-img post-10773 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042\" data-date=\"2026-06-17T17:47:20+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/le-brevet-dab-science-concernant-le-masitinib-dans-le-traitement-du-cancer-de-la-prostate-metastatique-hormono-resistant-a-ete-officiellement-delivre-aux-etats-unis-avec-une-duree-de-protecti\/\" title=\"Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042\" rel=\"bookmark\">Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/06\/17\/\" title=\"17h47\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-06-17T17:47:20+02:00\">17 juin 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 17\/06\/2026 \u2013\u00a0AB Science annonce aujourd\u2019hui que l\u2019Office am\u00e9ricain des brevets a officiellement d\u00e9livr\u00e9 un brevet relatif aux m\u00e9thodes de traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant (mCRPC) avec sa mol\u00e9cule phare, le masitinib [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/le-brevet-dab-science-concernant-le-masitinib-dans-le-traitement-du-cancer-de-la-prostate-metastatique-hormono-resistant-a-ete-officiellement-delivre-aux-etats-unis-avec-une-duree-de-protecti\/\" class=\"post-details details-type-link\" aria-label=\"Read more about Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10746\" data-date=\"2026-06-09T18:33:53+02:00\" data-name=\"AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&#039;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA\"><article class=\"post project-odd visible no-img post-10746 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&rsquo;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA\" data-date=\"2026-06-09T18:33:53+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-presentera-lors-du-congres-annuel-2026-de-lencals-les-donnees-de-survie-issues-du-programme-clinique-du-masitinib-dans-la-sla\/\" title=\"AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&rsquo;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA\" rel=\"bookmark\">AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&rsquo;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/06\/09\/\" title=\"18h33\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-06-09T18:33:53+02:00\">9 juin 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 09\/06\/2026 \u2013\u00a0AB Science a annonc\u00e9 aujourd&rsquo;hui que de nouvelles analyses issues de son essai de phase 3 dans la scl\u00e9rose lat\u00e9rale amyotrophique (AB10015) ont \u00e9t\u00e9 accept\u00e9es pour une pr\u00e9sentation lors de la r\u00e9union annuelle de l&rsquo;ENCALS (24-26 juin 2026, Madrid, Espagne) [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-presentera-lors-du-congres-annuel-2026-de-lencals-les-donnees-de-survie-issues-du-programme-clinique-du-masitinib-dans-la-sla\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&rsquo;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10727\" data-date=\"2026-06-02T17:59:30+02:00\" data-name=\"Stonegate Capital Partners actualise sa couverture de l&#039;action AB Science avec un objectif de cours de 4,25 EUR par action\"><article class=\"post project-odd visible no-img post-10727 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"Stonegate Capital Partners actualise sa couverture de l&rsquo;action AB Science avec un objectif de cours de 4,25 EUR par action\" data-date=\"2026-06-02T17:59:30+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/stonegate-capital-partners-actualise-sa-couverture-de-laction-ab-science-avec-un-objectif-de-cours-de-425-eur-par-action\/\" title=\"Stonegate Capital Partners actualise sa couverture de l&rsquo;action AB Science avec un objectif de cours de 4,25 EUR par action\" rel=\"bookmark\">Stonegate Capital Partners actualise sa couverture de l&rsquo;action AB Science avec un objectif de cours de 4,25 EUR par action<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/06\/02\/\" title=\"17h59\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-06-02T17:59:30+02:00\">2 juin 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 02\/06\/2026 \u2013\u00a0Stonegate Capital Partners actualise sa couverture de l&rsquo;action AB Science avec un objectif de cours de 4,25 EUR par action en valeur m\u00e9diane, sur la base des flux de tr\u00e9sorerie actualis\u00e9s [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/stonegate-capital-partners-actualise-sa-couverture-de-laction-ab-science-avec-un-objectif-de-cours-de-425-eur-par-action\/\" class=\"post-details details-type-link\" aria-label=\"Read more about Stonegate Capital Partners actualise sa couverture de l&rsquo;action AB Science avec un objectif de cours de 4,25 EUR par action\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10692\" data-date=\"2026-05-25T18:03:55+02:00\" data-name=\"AB Science annonce que le titre AB Science continue d\u2019\u00eatre couvert par Maxim Group, avec un objectif de cours de 4,00 \u20ac par action\"><article class=\"post project-odd visible no-img post-10692 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science annonce que le titre AB Science continue d\u2019\u00eatre couvert par Maxim Group, avec un objectif de cours de 4,00 \u20ac par action\" data-date=\"2026-05-25T18:03:55+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-que-le-titre-ab-science-continue-detre-couvert-par-maxim-group-avec-un-objectif-de-cours-de-400-e-par-action\/\" title=\"AB Science annonce que le titre AB Science continue d\u2019\u00eatre couvert par Maxim Group, avec un objectif de cours de 4,00 \u20ac par action\" rel=\"bookmark\">AB Science annonce que le titre AB Science continue d\u2019\u00eatre couvert par Maxim Group, avec un objectif de cours de 4,00 \u20ac par action<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/05\/25\/\" title=\"18h03\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-05-25T18:03:55+02:00\">25 mai 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 25\/05\/2026 \u2013\u00a0\u00c0 la suite de la publication des r\u00e9sultats de l&rsquo;exercice 2025 et de la souscription d&rsquo;une assurance pour les essais cliniques, Maxim Group r\u00e9it\u00e8re sa recommandation d&rsquo;achat sur le titre ab science avec un objectif de cours de 4,0 EUR par action [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-que-le-titre-ab-science-continue-detre-couvert-par-maxim-group-avec-un-objectif-de-cours-de-400-e-par-action\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science annonce que le titre AB Science continue d\u2019\u00eatre couvert par Maxim Group, avec un objectif de cours de 4,00 \u20ac par action\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><\/div><!-- iso-container|iso-grid --><\/div>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row css=\u00a0\u00bb.vc_custom_1601559325217{margin-top: 0px !important;padding-top: 0px !important;}\u00a0\u00bb][vc_column][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3983","page","type-page","status-publish","hentry","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939<\/title>\n<meta name=\"description\" content=\"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ab-science.com\/fr\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Accueil\" \/>\n<meta property=\"og:description\" content=\"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ab-science.com\/fr\/\" \/>\n<meta property=\"og:site_name\" content=\"AB Science\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-21T10:28:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"name\":\"AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-09-15T12:52:33+00:00\",\"dateModified\":\"2025-05-21T10:28:26+00:00\",\"description\":\"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Accueil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"name\":\"AB Science\",\"description\":\"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\",\"name\":\"AB Science\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"contentUrl\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"width\":120,\"height\":120,\"caption\":\"AB Science\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ab-science\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939","description":"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ab-science.com\/fr\/","og_locale":"fr_FR","og_type":"article","og_title":"Accueil","og_description":"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.","og_url":"https:\/\/www.ab-science.com\/fr\/","og_site_name":"AB Science","article_modified_time":"2025-05-21T10:28:26+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ab-science.com\/fr\/","url":"https:\/\/www.ab-science.com\/fr\/","name":"AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939","isPartOf":{"@id":"https:\/\/www.ab-science.com\/fr\/#website"},"datePublished":"2020-09-15T12:52:33+00:00","dateModified":"2025-05-21T10:28:26+00:00","description":"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.","breadcrumb":{"@id":"https:\/\/www.ab-science.com\/fr\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ab-science.com\/fr\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ab-science.com\/fr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.ab-science.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Accueil"}]},{"@type":"WebSite","@id":"https:\/\/www.ab-science.com\/fr\/#website","url":"https:\/\/www.ab-science.com\/fr\/","name":"AB Science","description":"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action","publisher":{"@id":"https:\/\/www.ab-science.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ab-science.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ab-science.com\/fr\/#organization","name":"AB Science","url":"https:\/\/www.ab-science.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","contentUrl":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","width":120,"height":120,"caption":"AB Science"},"image":{"@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/ab-science\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages\/3983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/comments?post=3983"}],"version-history":[{"count":0,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages\/3983\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/media?parent=3983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}